Published in Gynecol Oncol on October 28, 2010
Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013) 6.13
MiR-200, a new star miRNA in human cancer. Cancer Lett (2013) 1.50
miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. Am J Pathol (2012) 1.13
Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. Reprod Sci (2012) 1.11
A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance. PLoS One (2011) 1.05
Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis? Gynecol Oncol (2011) 1.03
miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. J Transl Med (2014) 1.01
Aberrant microRNA expression in endometrial carcinoma using formalin-fixed paraffin-embedded (FFPE) tissues. PLoS One (2013) 0.98
Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol (2011) 0.96
Minireview: The roles of small RNA pathways in reproductive medicine. Mol Endocrinol (2011) 0.92
miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer (2012) 0.90
miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas. Int J Clin Exp Pathol (2015) 0.89
Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications. Biomed Res Int (2013) 0.85
Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer. Mol Endocrinol (2012) 0.84
Small non-coding RNA deregulation in endometrial carcinogenesis. Oncotarget (2015) 0.82
Correlation between microRNA-421 expression level and prognosis of gastric cancer. Int J Clin Exp Pathol (2015) 0.78
Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer. Int J Mol Sci (2013) 0.78
The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers. J Cancer Prev (2015) 0.78
Studying the system-level involvement of microRNAs in Parkinson's disease. PLoS One (2014) 0.78
Non-coding RNAs in Uterine Development, Function and Disease. Adv Exp Med Biol (2016) 0.77
MicroRNA expression in human endometrial adenocarcinoma. Cancer Cell Int (2014) 0.77
MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis. Mol Cancer (2017) 0.76
miREC: a database of miRNAs involved in the development of endometrial cancer. BMC Res Notes (2015) 0.76
MicroRNA-421 Gene Polymorphism in Gastric Carcinoma. Med Sci Monit (2016) 0.75
Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer. Oncotarget (2016) 0.75
Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med (2017) 0.75
Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer. Cancer Genomics Proteomics (2017) 0.75
Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res (2008) 2.42
Cervical and ocular vestibular-evoked myogenic potentials in acute vestibular neuritis. Clin Neurophysiol (2011) 2.24
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol (2012) 1.49
Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes. Surg Endosc (2010) 1.46
Clinical characteristics of adnexal masses in Korean children and adolescents: retrospective analysis of 409 cases. J Minim Invasive Gynecol (2010) 1.45
Single port access laparoscopic adnexal surgery. J Minim Invasive Gynecol (2009) 1.40
Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res (2012) 1.36
Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer (2007) 1.33
Single-port access laparoscopic-assisted vaginal hysterectomy: a novel method with a wound retractor and a glove. J Minim Invasive Gynecol (2009) 1.32
Benign metastasizing leiomyoma with multiple lymph node metastasis: a case report. Cancer Res Treat (2011) 1.29
Adenoid cystic carcinoma of the Bartholin's gland: report of two cases and review of the literature. Gynecol Oncol (2005) 1.25
Embryonic natural orifice transumbilical endoscopic surgery (E-NOTES) for adnexal tumors. Surg Endosc (2009) 1.22
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol (2011) 1.22
Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes. Eur J Obstet Gynecol Reprod Biol (2010) 1.19
Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett (2007) 1.15
Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients. Int J Gynecol Cancer (2013) 1.15
Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol (2011) 1.15
Ecology of H3 avian influenza viruses in Korea and assessment of their pathogenic potentials. J Gen Virol (2008) 1.13
Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol (2005) 1.10
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer. J Mol Cell Biol (2012) 1.10
AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med (2011) 1.08
Multiple vaginal mullerian cysts: a case report and review of literature. Arch Gynecol Obstet (2008) 1.07
Single-port access subtotal hysterectomy with transcervical morcellation: a pilot study. J Minim Invasive Gynecol (2009) 1.07
The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol (2009) 1.06
Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol (2010) 1.04
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Gynecol Oncol (2009) 1.03
Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma. Gynecol Oncol (2007) 1.03
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02
Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog (2007) 1.02
Metastatic skin lesions on lower extremities in a patient with recurrent serous papillary ovarian carcinoma: a case report and literature review. Cancer Res Treat (2012) 1.00
Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results. Int J Radiat Oncol Biol Phys (2007) 0.99
Primary small cell carcinoma of the endometrium: report of a case with immunochemical studies. J Reprod Med (2010) 0.99
Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol (2010) 0.98
A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. J Gynecol Oncol (2008) 0.98
Single-port access laparoscopic staging operation for a borderline ovarian tumor. J Gynecol Oncol (2011) 0.97
Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma. Clin Cancer Res (2013) 0.97
High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion. Eur J Cancer (2012) 0.96
Bone metastasis in primary endometrial carcinoma: features, outcomes, and predictors. Int J Gynecol Cancer (2014) 0.96
A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA. Gynecol Oncol (2010) 0.96
Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes. Radiology (2012) 0.96